An updated overview of e-cigarette impact on human health.

Fecha de publicación: Fecha Ahead of Print:

Autores de INCLIVA

Grupos y Plataformas de I+D+i

Abstract

The electronic cigarette (e-cigarette), for many considered as a safe alternative to conventional cigarettes, has revolutionised the tobacco industry in the last decades. In e-cigarettes, tobacco combustion is replaced by e-liquid heating, leading some manufacturers to propose that e-cigarettes have less harmful respiratory effects than tobacco consumption. Other innovative features such as the adjustment of nicotine content and the choice of pleasant flavours have won over many users. Nevertheless, the safety of e-cigarette consumption and its potential as a smoking cessation method remain controversial due to limited evidence. Moreover, it has been reported that the heating process itself can lead to the formation of new decomposition compounds of questionable toxicity. Numerous in vivo and in vitro studies have been performed to better understand the impact of these new inhalable compounds on human health. Results of toxicological analyses suggest that e-cigarettes can be safer than conventional cigarettes, although harmful effects from short-term e-cigarette use have been described. Worryingly, the potential long-term effects of e-cigarette consumption have been scarcely investigated. In this review, we take stock of the main findings in this field and their consequences for human health including coronavirus disease 2019 (COVID-19).

Datos de la publicación

ISSN/ISSNe:
1465-9921, 1465-993X

RESPIRATORY RESEARCH  BIOMED CENTRAL LTD

Tipo:
Article
Páginas:
151-151
PubMed:
34006276

Citas Recibidas en Web of Science: 247

Documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • COVID-19; E-cigarette; Electronic cigarette; Flavourings; Humectants; Nicotine; Smoking cessation tool; Tobacco; Toxicity

Campos de Estudio

Financiación

Proyectos y Estudios Clínicos

A multidisciplinary project to advance in basic mechanisms, diagnosis, prediction, and prevention of cardiac damage in reperfused acute myocardial infarction.

Investigador Principal: VICENT BODÍ PERIS

PIE15/00013 . INSTITUTO SALUD CARLOS III . 2016

RETOS 2017. MODULACION FARMACOLOGICA DEL SISTEMA INMUNE COMO DIANA CLAVE EN LA PREVENCION DE LA ENFERMEDAD CARDIOVASCULAR ASOCIADA A DESORDENES METABOLICOS. SINTESIS DE FARMACOS NOVEDOSOS

Investigador Principal: MARIA JESUS SANZ FERRANDO

SAF2017-89714-R . MINISTERIO ECONOMIA Y COMPETITIVIDAD . 2018

Identificación de nuevos mecanismos implicados en la angiogénesis e inflamación en pacientes obesos. Modulación por ligandos de receptores nucleares constitutivos de androstano.

Investigador Principal: JOSE TOMAS REAL COLLADO

PI18/00209 . INSTITUTO SALUD CARLOS III . 2019

Efecto de la cirugía bariátrica en la inflamación vascular en pacientes con obesidad morbida y diabéticos.

Investigador Principal: LAURA PIQUERAS RUIZ

AICO/2019/250 . CONSELLERIA EDUCACION/INNOVACION,UNIVERSIDADES, CIENCIA Y SOCIEDAD DIGITAL/EMPLEO . 2019

'Una aproximación translacional desde la clínica a la experimentación animal: Estudio del papel del eje CCL11/CCR3 y la inflamación eosinofílica en la patología cardiovascular asociada a desórdenes metabólicos. -

Investigador Principal: MARIA JESUS SANZ FERRANDO

PROMETEO2019/032 . CONSELLERIA EDUCACION/INNOVACION,UNIVERSIDADES, CIENCIA Y SOCIEDAD DIGITAL/EMPLEO . 2020

CDEI-04/20-A GENT LAURA PIQUERAS (2019/200) CONTRATO

Investigador Principal: LAURA PIQUERAS RUIZ

2019/200C . CONSELLERIA DE SANIDAD

Cita

Compartir